HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuyuki Suzuki Selected Research

Massive Hepatic Necrosis

8/2009Nucleotide substitutions of hepatitis E virus genomes associated with fulminant hepatitis and disease severity.
7/2009Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities.
6/2008Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
7/2007Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities.
4/2007Genetic analysis of hepatitis A virus protein 2C in sera from patients with fulminant and self-limited hepatitis A.
3/2007Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection.
8/2006Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
4/2006Analysis of the full-length genome of genotype 4 hepatitis E virus isolates from patients with fulminant or acute self-limited hepatitis E.
11/2004Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey.
2/2003Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuyuki Suzuki Research Topics

Disease

20Liver Cirrhosis (Hepatic Cirrhosis)
10/2019 - 11/2001
20Hepatitis
11/2012 - 02/2002
19Hepatocellular Carcinoma (Hepatoma)
10/2019 - 05/2002
17Neoplasms (Cancer)
01/2018 - 05/2002
14Infections
12/2015 - 02/2002
12Hepatic Encephalopathy
02/2021 - 12/2004
12Massive Hepatic Necrosis
08/2009 - 11/2001
10Diarrhea
10/2020 - 12/2002
10Liver Diseases (Liver Disease)
05/2018 - 11/2001
8Acute Liver Failure (Fulminant Hepatic Failure)
12/2014 - 07/2004
7Acidosis
12/2021 - 12/2002
7Inflammation (Inflammations)
10/2020 - 08/2004
7Fibrosis (Cirrhosis)
05/2018 - 11/2003
6Mastitis
03/2021 - 01/2016
5Hepatitis A (Hepatitis, Infectious)
07/2009 - 02/2003
4Body Weight (Weight, Body)
12/2021 - 11/2001
4Hyperammonemia
01/2021 - 11/2014
4Bronchopneumonia
07/2019 - 07/2008
4Neoplasm Metastasis (Metastasis)
01/2018 - 08/2004
4Hepatitis B
01/2014 - 11/2004
4Chronic Hepatitis B
01/2014 - 06/2009
4Constipation
01/2013 - 09/2005
4Stomach Neoplasms (Stomach Cancer)
11/2012 - 01/2010
4Hemorrhage
04/2011 - 02/2007
4Ulcer
07/2010 - 09/2007
4Carcinogenesis
06/2010 - 05/2004
4Brain Diseases (Brain Disorder)
07/2009 - 12/2004
4Liver Failure
07/2009 - 12/2004
4Sarcoma (Soft Tissue Sarcoma)
02/2009 - 06/2005
3Edema (Dropsy)
05/2018 - 07/2009
3Crohn Disease (Crohn's Disease)
01/2018 - 07/2009
3Jaw Diseases (Jaw Disease)
06/2017 - 07/2016
3Peritonitis
12/2015 - 09/2005
3Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2013 - 09/2005
3Hepatitis E
11/2012 - 01/2005
3Breast Neoplasms (Breast Cancer)
11/2011 - 08/2002
3Obesity
01/2011 - 05/2005
3Chronic Hepatitis C
01/2010 - 11/2003
3Thrombosis (Thrombus)
03/2009 - 07/2004
3Renal Cell Carcinoma (Grawitz Tumor)
08/2005 - 05/2003
2Immunoglobulin G4-Related Disease
11/2021 - 01/2021
2Metaplasia
12/2020 - 01/2010

Drug/Important Bio-Agent (IBA)

12Branched-Chain Amino AcidsIBA
01/2021 - 12/2004
12Proteins (Proteins, Gene)FDA Link
09/2015 - 08/2004
10Amino AcidsFDA Link
10/2020 - 12/2004
8Serum AlbuminIBA
02/2021 - 04/2004
8AntigensIBA
01/2014 - 02/2002
7Biomarkers (Surrogate Marker)IBA
10/2020 - 11/2001
7RNA (Ribonucleic Acid)IBA
11/2012 - 09/2002
6IronIBA
05/2021 - 02/2012
6ZincIBA
01/2021 - 02/2012
6EnzymesIBA
11/2012 - 02/2002
6BilirubinIBA
01/2012 - 11/2001
5Indicators and Reagents (Reagents)IBA
03/2021 - 02/2006
5EndotoxinsIBA
07/2020 - 01/2016
5InterferonsIBA
01/2018 - 11/2003
5Pharmaceutical PreparationsIBA
01/2017 - 11/2004
5DNA (Deoxyribonucleic Acid)IBA
03/2006 - 05/2002
4Immunoglobulin G (IgG)IBA
11/2021 - 11/2012
4Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 02/2009
4CholesterolIBA
09/2015 - 04/2005
4CytokinesIBA
04/2013 - 08/2004
4Immunoglobulin M (IgM)IBA
11/2012 - 09/2002
4Alanine Transaminase (SGPT)IBA
09/2010 - 11/2001
4Connexin 43 (Connexin43)IBA
11/2008 - 06/2005
4ConnexinsIBA
09/2008 - 05/2003
3HaptoglobinsIBA
05/2021 - 10/2020
3Serum Amyloid A Protein (Serum Amyloid A)IBA
05/2021 - 07/2020
3Rifaximin (L 105)FDA Link
01/2021 - 05/2018
3AmmoniaIBA
01/2021 - 12/2004
3Messenger RNA (mRNA)IBA
07/2020 - 06/2008
3Glucose (Dextrose)FDA LinkGeneric
11/2017 - 05/2005
3Immunoglobulin A (IgA)IBA
06/2017 - 01/2005
3ElementsIBA
02/2017 - 01/2005
3Hemoglobins (Hemoglobin)IBA
01/2017 - 04/2005
3PowdersIBA
01/2013 - 03/2009
31- (2,6- dimethylphenoxy)- 2- (3,4- dimethoxyphenylethylamino)propaneIBA
01/2013 - 03/2009
3SuspensionsIBA
01/2013 - 04/2007
3Cisplatin (Platino)FDA LinkGeneric
01/2013 - 03/2009
3AntibodiesIBA
11/2012 - 09/2002
3LipidsIBA
11/2011 - 11/2003
3Triglycerides (Triacylglycerol)IBA
01/2011 - 04/2005
3Antiviral Agents (Antivirals)IBA
09/2009 - 08/2006
3NucleotidesIBA
08/2009 - 04/2006
3Trace Elements (Biometals)IBA
07/2008 - 07/2006
3AcidsIBA
09/2007 - 08/2002
3SolutionsIBA
05/2007 - 12/2002
3Gap Junction beta-1 ProteinIBA
11/2006 - 05/2003
3ImmunosorbentsIBA
02/2006 - 02/2002
3urinastatin (MR 20)IBA
08/2004 - 02/2002
2Carnitine (L-Carnitine)FDA LinkGeneric
01/2021 - 07/2019
2Warfarin (Coumadin)FDA LinkGeneric
01/2021 - 01/2014
2SodiumIBA
11/2020 - 11/2017
2CopperIBA
10/2020 - 02/2012
2Amine Oxidase (Copper-Containing)IBA
10/2020 - 10/2019

Therapy/Procedure

23Therapeutics
01/2021 - 07/2004
4Renal Dialysis (Hemodialysis)
12/2015 - 05/2004
4Liver Transplantation
01/2012 - 07/2004
4Aftercare (After-Treatment)
09/2011 - 09/2005
3Intravenous Infusions
05/2007 - 12/2002